Mineralocorticoid receptor blockers for moderate kidney dysfunction: more merit than ever?

Hypertens Res. 2021 Oct;44(10):1352-1354. doi: 10.1038/s41440-021-00690-6. Epub 2021 Jul 15.

Authors

Masashi Mukoyama¹, Takashige Kuwabara², Masataka Adachi²

Affiliations

¹ Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan. mmuko@kumamoto-u.ac.jp.
² Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan.

PMID: 34267356
DOI: 10.1038/s41440-021-00690-6

No abstract available

Publication types

Editorial

MeSH terms

Humans
Kidney
Mineralocorticoid Receptor Antagonists / therapeutic use*
Receptors, Mineralocorticoid
Renal Insufficiency* / drug therapy

Substances

Mineralocorticoid Receptor Antagonists
Receptors, Mineralocorticoid